Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

EGFR pathway regulates the cellular interactome within the liver fibrotic niche

ABSTRACT: EGFR pathway regulates the cellular interactome within the liver fibrotic niche

PROVIDER: PRJNA1105063 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR28814100_1.fastq.gz	Fastqsanger.gz
	SRR28814100_2.fastq.gz	Fastqsanger.gz
	SRR28814101_1.fastq.gz	Fastqsanger.gz
	SRR28814101_2.fastq.gz	Fastqsanger.gz
	SRR28814102_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 224

Similar Datasets

EGFR pathway regulates the cellular interactome within the liver fibrotic niche

Project description:RNA-seq analysis was performed in samples from WT and ΔEGFR mice (which expresses an inactive truncated form of the EGFR in hepatocytes). Samples were either treated with Mineral oil or CCl4.

2024-04-30 | GSE265969 | GEO

Single-cell RNA-seq reveals the midkine-mediated immune microenvironment dysfunction in human keloids fibrotic niche

Project description:A keloid scar is recognized as the most intractable skin pathological scar due to its continuous overgrowth, invasion of adjacent boundary and high recurrence rate. Heterogeneity of fibroblasts or vascular endothelial cells was previously characterized, while the immune microenvironment within this fibrotic niche remains largely unknown.

2024-11-25 | GSE191067 | GEO

Fibrotic Response to anti-CSF-1R Treatment Potentiates Glioblastoma Recurrence

Project description:Treatment of glioblastoma with anti-CSF-1R immunotherapy, radiotherapy, or surgical tumor resection were found to all induce a fibrotic response to treatment, which was highly associated with tumor recurrence. To investigate the drivers of fibrotic treatment response we performed multi-omic analysis of the glioblastoma microenvironment following treatment with anti-CSF-1R immunotherapy. Studies consisted of mass spectrometry proteomic analysis, single cell transcriptomics, and high-dimensional spatial analysis. These data identified a protective spatial niche that supported tumor cell survival following treatment, ultimately leading to tumor recurrence. Therapeutic inhibition of fibrotic treatment response blocked the formation of this niche, and significantly improved survival in anti-CSF-1R preclinical trials

2024-08-12 | PXD041689 | Pride

Unique microglial transcriptomic signature within the hippocampal neurogenic niche

Project description:Unique microglial transcriptomic signature within the hippocampal neurogenic niche

| PRJNA755677 | ENA

Resolving the fibrotic niche of human liver cirrhosis using single-cell transcriptomics

Project description:Resolving the fibrotic niche of human liver cirrhosis using single-cell transcriptomics

| PRJNA561303 | ENA

Circulating proinflammatory cytokines alter transcriptional activity within fibrotic tissue of Dupuytren’s disease patients

Project description:Circulating proinflammatory cytokines alter transcriptional activity within fibrotic tissue of Dupuytren’s disease patients

| PRJNA716676 | ENA

JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia (scRNA-seq)

Project description:The hair follicle stem cell niche is an immune-privileged microenvironment, characterized by reduced antigen presentation, thus shielding against permanent immune-mediated tissue damage. In this study, we demonstrated the protective role of hair follicle-specific epidermal growth factor receptor (EGFR) against scarring hair follicle destruction. Mechanistically, disruption of EGFR signalling generated a cell-intrinsic hypersensitivity within the JAK-STAT1 pathway, which, synergistically with interferon gamma expressing CD8 T-cell and NK-cell-mediated inflammation, compromised the stem cell niche. Hair follicle-specific genetic depletion of either JAK1/2 or STAT1 or therapeutic inhibition of JAK1/2 ameliorated the inflammation, restored skin barrier function and activated the residual stem cells to resume hair growth in mouse models of epidermal and hair follicle-specific EGFR deletion. Skin biopsies from EGFR inhibitor-treated and cicatricial alopecia patients indicated active STAT1 signalling and interferon target expression. Notably, a case study of folliculitis decalvans, characterized by progressive hair loss, scaling and perifollicular erythema, demonstrated successful treatment with JAK1/2 inhibition. Our findings offer molecular insights and present a mechanism-based therapeutic strategy for addressing chronic folliculitis associated with EGFR-inhibitor anti-cancer therapy and cicatricial alopecia.

2024-07-31 | GSE273572 | GEO

Expression data from EGFR WT or EGFR mutant NSCLC with or without erlotinib

Project description:Non-small cell lung cancers (NSCLCs) harboring activating EGFR mutants show dramatic responses to EGFR TKIs, such as erlotinib and geffitinib. However, nearly all patients show relapse within 1 year after initial treatment. We used microarrays to detail global gene expression changes in EGFR mutant cells vs. WT cells responding to erlotinib. 4 EGFR mutant and 4 WT NSCLC cells were treated with or without erlotinib for 24 hr, followed by RNA extraction and hybridization on Affymetrix microarrays.

2014-05-16 | E-GEOD-57156 | biostudies-arrayexpress

Cell-cell interactome of the hematopoietic niche and its changes in acute myeloid leukemia

Project description:Cell-cell interactome of the hematopoietic niche and its changes in acute myeloid leukemia

| PRJNA947256 | ENA

JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia (RNA-seq of HFSC)

2024-07-31 | GSE273571 | GEO